Advertisement
Australia markets closed
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • AUD/USD

    0.6444
    +0.0007 (+0.11%)
     
  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     
  • OIL

    81.94
    -0.75 (-0.91%)
     
  • GOLD

    2,394.60
    +6.20 (+0.26%)
     
  • Bitcoin AUD

    95,564.93
    -2,682.15 (-2.73%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Why Has Valeant Stock Fallen in June?

Why Has Valeant Stock Fallen in June?

Valeant Pharmaceuticals (VRX) stock has been falling in June. Valeant’s division Ortho Dermatologics received a CRL (complete response letter) from the FDA on June 18 for its new drug application for Duobril, which treats plaque psoriasis. Valeant’s Siliq, which treats moderate to severe psoriasis, received FDA approval earlier.